Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 1,799 | 2,937 | 3,477 | 4,166 | 4,121 |
| Cost of Goods | 4,732 | 12,094 | 3,991 | 3,749 | -3,913 |
| Gross Profit | -2,933 | -1,514 | -514 | 417 | -3,722 |
| Operating Expenses | 732 | 5,592 | 3,029 | 2,484 | -2,553 |
| Operating Income | -2,933 | -14,655 | -2,552 | -1,318 | 9,674 |
| Interest Expense | 382 | 1,326 | 444 | 435 | 8 |
| Other Income | 1,907 | 7,648 | 0 | 0 | -18,470 |
| Pre-tax Income | -1,408 | -8,333 | -2,996 | -1,753 | -8,804 |
| Income Tax | N/A | 0 | 0 | 0 | -296 |
| Net Income Continuous | -6,162 | -3,584 | -2,996 | -1,753 | -3,500 |
| Net Income | $-6,162 | $-3,584 | $-2,996 | $-1,753 | $-3,500 |
| EPS Basic Total Ops | -29.00 | -18.50 | -13.00 | -11.00 | -22.00 |
| EPS Basic Continuous Ops | -28.83 | -18.57 | -13.17 | -11.12 | -22.19 |
| EPS Diluted Total Ops | -29.00 | -18.50 | -13.00 | -11.00 | -22.00 |
| EPS Diluted Continuous Ops | -28.83 | -18.57 | -13.17 | -11.12 | -22.19 |
| EBITDA(a) | $-2,933 | $-14,126 | $-1,892 | $-785 | $9,674 |